Skip to main content

Advertisement

Log in

Donor-Transmitted Malignancy in a Liver Transplant Recipient: A Case Report and Review of Literature

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Donor-transmitted malignancy is a rare complication of organ transplantation. This case illustrates a donor-transmitted adenocarcinoma in a patient 11 months after an orthotopic liver transplant for cryptogenic cirrhosis and hepatocellular carcinoma (HCC). Diagnosis of donor-transmitted malignancy may be challenging and can be confused with HCC recurrence. A timely diagnosis is crucial as a delay may limit treatment options. Biopsy of newly found liver lesions and the use of karyotypic and microsatellite analysis may be essential for diagnosis. Protocols should be in place to help recognize and limit the incidence of donor-transmitted malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. McPhaul JJ, McIntosh DA. Tissue transplantation still vexes. N Engl Med. 1965;272:105.

    Google Scholar 

  2. Kauffman HM, McBride MA, Cherikh WS, Spain PC, Marks WH, Roza AM. Transplant tumor registry: donor related malignancies. Transplantation. 2002;74:358–362.

    Article  Google Scholar 

  3. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl Med. 1996;334:693–699.

    Article  CAS  Google Scholar 

  4. Donovan JA, Simmons FA, Esrason KT, et al. Donor origin of a post-transplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping. Transplantation. 1997;63:80–84.

    Article  PubMed  CAS  Google Scholar 

  5. Pfeiffer H, Ortmann C, Klein A, Brinkmann B. Origin of hepatocellular carcinoma recurring after allotransplantation revealed by microsatellite analysis. J Clin Pathol. 1997;50:792–794.

    Article  PubMed  CAS  Google Scholar 

  6. Ng IOL, Shek TWH, Thung SN, et al. Microsatellite analysis in post-tranplantation lymphoproliferative disorder to determine donor/recipient origin. Mod Pathol. 2000;13:1180–1185.

    Article  PubMed  CAS  Google Scholar 

  7. Kakar S, Burgart LJ, Charlton MR, Saito Y, Halling K, Thibodeau SN. Origin of adenocarcinoma in a transplanted liver determined by microsatelliteanalysis. Hum Pathol. 2002;33:435–436.

    Article  PubMed  Google Scholar 

  8. Ison MG, Nalesnik MA. An update on donor-derived disease transmission in organ transplantation. Am J Transplant. 2011;11:1123–1130.

    Article  PubMed  CAS  Google Scholar 

  9. Detry O, Honore P, Jacquet N. Management of recipients of hepatic allografts harvested from donors with malignancy diagnosed shortly after transplantation. Clin Tranplant. 1998;12:579–581.

    CAS  Google Scholar 

  10. Florman S, Bowne W, Kim-Schluger L, et al. Unresectable squamous cell carcinoma of donor origin treated with immunosuppression withdrawal and liver transplantation. Am J Transplant. 2003;4:278–282.

    Article  Google Scholar 

  11. Gray BN, Anderson JE, Burton MA, et al. Regression of liver metastases following treatment with yttrium-90 microspheres. Aust NZ J Surg. 1992;62:105–110.

    CAS  Google Scholar 

  12. Birkeland SA, Storm HH. Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation. 2002;74:1409–1413.

    Article  PubMed  Google Scholar 

  13. Buell JF, Beebe TM, Trofe J, et al. Donor transmitted malignancies. Ann Transplant. 2004;9:53–56.

    PubMed  Google Scholar 

  14. Nalesnik MA, Woodle ES, DiMaio JM, et al. Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant. 2011;11:1140–1147.

    Article  PubMed  CAS  Google Scholar 

  15. Lipschutz GS, Baxter-Lowe LA, Nguyen T, Jones KD, Ascher NL, Feng S. Death from donor-transmitted malignancy despite emergency liver transplantation. Liver Transplant. 2003;9:1102–1107.

    Article  Google Scholar 

  16. Fiorentino M, D’Errico A, Corti B, et al. A multiorgan donor cancer screening protocol: the Italian Emilia–Romagna region experience. Transplantation. 2003;76:1695–1699.

    Article  PubMed  Google Scholar 

  17. Zucchini N, Fiorentino M, Grigioni AD, et al. The Italian multiorgan donor cancer screening protocol: 2002–2005 experience. Transplantation. 2008;85:S57–S60.

    Article  PubMed  Google Scholar 

  18. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2010 Annual Data Report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011.

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brian Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, B., Woreta, T., Chen, PH. et al. Donor-Transmitted Malignancy in a Liver Transplant Recipient: A Case Report and Review of Literature. Dig Dis Sci 58, 1185–1190 (2013). https://doi.org/10.1007/s10620-012-2501-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-012-2501-0

Keywords

Navigation